Effectiveness and security analysis of 577nm subthreshold micropulse laser in the treatment of aCSC with full coverage of serous detachment area

Author:

Nie Xiaomei1,Liang Qian1,Bi Yege1,Li Mingbo1,Ma Hong1,Liu Hongtao1,Shanjun Cai2

Affiliation:

1. The Second Affiliated Hospital of Zunyi Medical University

2. Zunyi Medical University

Abstract

Abstract Objective 5X5 matrix thick method of 577 nm substituting micropulsive lasers (SML) was used to treat acute central serous chorioretinopathy (aCSC) with leakage essence within 500µm of the fovea to perform full coverage of the serous detachment area. The effectiveness and safety of this method was evaluated. Methods Patients were enrolled and treated with 577 nm SML by the same physicianwith unified operation procedure. 577nm SML was applied to aCSC to treat subretinal fluid (SRF) including PED area without full coverage of the spot interval. These are contrased that the best corrected visual acuity (BCVA), central retina thickness (CRT), choroidal vascular index (CVI). SPSS 18.0 was used to perform repeated measures analysis of variance on LogMAR BCVA and CRT. Paired t-test analysis for CVI was performed with SPSS 18.0.and Optical coherence tomography (OCT) was used to observe the anatomical structure and retinal destruction . Results 23 patients with 24 eyes were collected and followed up. The results showed that LogMAR BCVA and CRT of 1 week, 1 month, and 3 months after treatment, compared with baseline had statistically significant(p < 0.01);1w after treatment compared with 1m after treatment, which has statistically significant༈p < 0.01༉༛1m, 3m after treatment compared with p > 0.05, which was not statistically significant. In addition, baseline CVI compared with 3 months after treatment, which was statistically significant (P < 0.05). There was no retinal neovascularization (CNV), and only 3 eyeballs had granular hyperreflective deposition under the neuroepithelial layer, but CRT is normal and no subretinal fluid (SRF), macular edem. Conclusion 577 nm SML is effective in the treatment of aCSC with less side effects. It is the first choice for aCSC within 500um from the fovea. On this basis, it is safe to fully cover the serous detachment region, and it can accelerate the soaking up of serous liquid under the neuroepithelial layer. It is a good choice for aCSC with insignificant leakage points or multiple leakage points.

Publisher

Research Square Platform LLC

Reference19 articles.

1. Central serou chorior-etinopathy in younger and older adults;Spaide RF;Ophthalmology,1996

2. Central serous chorioretinopathy;Wang M;Acta Ophthal-mol (Copenh),2008

3. Treatment of chronic central serous chorioretino pathy with oral methotrexate;Abrishami Mousavi;J. 2015.Ocul. Pharmacol. Ther

4. Liegl R, Ulbig MW. Central serous chorioretinopathy.Ophthalmologica.2014;232(2):65 – 76.

5. Long-term macular function in eyes with central serous chorioretinopathy;Gürlü NVB;Clin Experiment Ophthalmol,2005

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3